Skin & hair

The Next Steps After Creams for Hand Eczema

Save

Hand and foot eczema with recurring blisters doesn't always respond to the same steroid creams that work for eczema elsewhere on the body, and when it doesn't, the escalation path looks different too — localized light therapy first, then a small menu of systemic options. This article walks through what that escalation actually involves and how to know when it's time to ask for it.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Continue in Claude

Open a chat with this article’s link already in the message, and keep asking questions there. Claude reads the article and its sources; nothing about you is included.

Continue in Claude →

The button opens the Claude desktop app and fills in the message for you to review before sending. No desktop app, or reading on a phone? Copy the prompt and paste it into any AI.

Why Hand and Foot Eczema Gets Its Own Treatment Ladder

Dyshidrotic eczema, also called pompholyx, causes small, intensely itchy blisters that erupt along the sides of the fingers, the palms, or the soles, and it behaves differently enough from eczema on thinner skin elsewhere on the body that its dyshidrotic eczema treatment ladder is built around that difference. Palm and sole skin is thick, which means topical medication has to work harder to penetrate, and hands are in near-constant contact with water, soap, and friction that can undo treatment progress within the same day. That distinction also shapes how a course of treatment is judged: hand and foot flares that don't respond within a defined trial period tend to move to the next tier faster than eczema elsewhere might, simply because there's less room to wait when grip and daily hand use are affected.

Because of that, the standard eczema treatment sequence — moisturizer, then a standard-potency topical steroid — usually gets compressed or skipped for the hands and feet in favor of starting with a higher-potency steroid, on the logic that thick palm and sole skin can tolerate more concentrated topical treatment than thinner skin can.

When High-Potency Topical Steroids Stop Being Enough

A high-potency steroid cream for dyshidrotic eczema, used correctly for a defined course, clears many episodes, but recurring or persistent blistering that keeps coming back despite consistent use — or that covers enough of the palms and soles to interfere with using the hands for daily tasks — is the signal to move beyond topical treatment 1. Because high-potency steroids thin the skin with prolonged continuous use, they're not meant to be used indefinitely as a maintenance strategy; dermatology guidelines generally favor stepping up to the next tier over extending high-potency steroid use past a defined course 1.

That point — when hand eczema outruns the cream — is exactly what this escalation path addresses. The next tier for the hands and feet specifically is usually localized phototherapy rather than jumping straight to a systemic medication, mirroring the same principle used in eczema treatment more broadly: treat the skin directly before moving to something that affects the whole body 2.

Localized Phototherapy: PUVA Soaks for Hands and Feet

For hands and feet specifically, phototherapy is often delivered as a localized PUVA treatment — soaking the hands or feet in a psoralen solution that makes skin more responsive to UVA light, then exposing them in a dedicated hand-and-foot light unit — rather than a full-body narrowband UVB session, because the palms and soles are thick enough to need a treatment that penetrates more deeply. Sessions typically happen two to three times a week for several weeks, with gradual dose increases similar to full-body phototherapy elsewhere.

A separate look at phototherapy for eczema on other parts of the body covers session mechanics that overlap here; the hand-and-foot version differs mainly in the psoralen soak step and the smaller, targeted equipment used.

Systemic Options When Light Therapy Isn't Enough

When localized phototherapy doesn't control dyshidrotic eczema after a reasonable course, the next tier is a systemic medication — a short course of oral steroids for a severe flare, followed by a longer-term option such as an oral immunosuppressant or a biologic for eczema, depending on how the case behaves and what else has been tried 2. This is the same systemic tier used for eczema elsewhere on the body, applied here because dyshidrotic eczema is a variant of the same underlying disease process rather than a separate condition with its own systemic drug menu. Which specific systemic option a clinician recommends first also depends on other factors — overall health, other medications, and how quickly control is needed — rather than following one fixed sequence for every case.

Getting to this tier usually means documenting that both a high-potency topical steroid and a localized phototherapy course were genuinely tried, since that history is typically what a dermatologist and, often, an insurer want to see before approving a systemic medication.

What Slows Recovery Down Between Tiers

Hands are hard to protect from irritants during any tier of treatment, and repeated contact with water, soap, hand sanitizer, and friction from daily tasks can re-trigger blistering even while an otherwise appropriate treatment is working. That kind of barrier cream hand eczema care — a plain moisturizer applied immediately after washing, and gloves for wet work like dishwashing or cleaning — supports whatever tier of active treatment is underway rather than replacing it; a Cochrane review of emollients in eczema found regular moisturizer use reduces flare frequency and the amount of topical steroid needed 3.

Identifying and reducing a specific irritant or, less commonly, an allergen behind a person's flares can also shorten how long each tier needs before the next step is considered, though for many people no single trigger is ever clearly identified.

When to Ask for the Next Step

Bringing a specific account to the next appointment — how long the current treatment has been used, how consistently, and what's changed or not changed — moves the conversation toward escalation faster than a general report that 'the cream isn't working.' Photos of a flare at its worst are useful too, since hands often look better by the time of an appointment than they did during the blistering itself. Bringing that account in writing, even briefly, tends to be more useful than trying to recall the details verbally during a short appointment.

Recurring flares that interfere with grip, work, or sleep, blistering that spreads beyond the hands and feet, or any sign of infection — increasing pain, spreading redness, or pus — are all reasonable reasons to ask about moving to the next tier rather than waiting for a scheduled follow-up.

Common questions

Dyshidrotic eczema specifically causes small, intensely itchy blisters along the fingers, palms, or soles, while hand eczema more broadly can also include dryness, cracking, and redness without blistering. The treatment ladders overlap heavily, but the blistering pattern is what distinguishes dyshidrotic eczema specifically.

Most localized PUVA courses run several weeks at two to three sessions a week before meaningful improvement shows, similar to full-body phototherapy timelines. A single session, or even the first week or two, usually isn't enough to judge whether the course is working, so sticking with the full schedule matters more than judging it too early.

Many people report flares during stressful periods, though stress is one of several possible triggers alongside irritants, sweating, and metal contact, and no single trigger explains every case. Identifying a personal pattern, where one exists, is more useful than assuming stress is always the cause.

No. It's an inflammatory skin condition, not an infection, and it can't be passed to another person through contact. The blisters can look concerning, but they don't carry the risk of spreading to someone else the way a contagious skin condition would.

For many people it's a recurring condition with flares and remissions over years rather than something that's cured outright, though flares can become less frequent and less severe with consistent treatment and trigger management. A stretch without a flare doesn't mean it won't return.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When Hand Eczema Needs a Faster Evaluation

  • —blistering that spreads beyond the hands and feet or covers a large portion of either
  • —increasing pain, spreading redness, warmth, or pus suggesting a skin infection
  • —flares that consistently interfere with grip, work, or sleep despite treatment
  • —no improvement after a genuine course of high-potency steroid treatment

This article describes dyshidrotic eczema treatment in general terms; it can't determine the right treatment tier for a specific case — that decision is made with a clinician who can examine the hands and feet directly.

References

  1. 1.Sidbury R, Alikhan A, Bercovitch L, et al. (2023). Guidelines of care for the management of atopic dermatitis in adults with topical therapies. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2022.12.029AAD recommendations on topical corticosteroid use in eczema, including the rationale for not using high-potency steroids indefinitely, applied here to hand and foot eczema.
  2. 2.Sidbury R, Davis DM, Alikhan A, et al. (2024). Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. Journal of the American Academy of Dermatology. PMID 37943240AAD recommendations establishing phototherapy and systemic therapy as the tier above topical treatment for eczema, applied here to the hand-and-foot escalation sequence.
  3. 3.van Zuuren EJ, Fedorowicz Z, Christensen R, et al. (2017). Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews. PMID 28432721 ✓Cochrane review (77 RCTs) showing regular moisturizer use reduces flare frequency and topical steroid need in eczema, supporting the barrier-care recommendation between treatment tiers.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library